Abstract:OBJECTIVE:This study sought to isolate and identify the proteins that interact with ataxin-3, to confirm the interacted domain, and to provide new clues for exploring the function of ataxin-3 and the pathogenesis of spinocerebellar ataxia type 3 and Machado-Joseph disease (SCA3/MJD).METHODS:Yeast two-hybrid screen (MATCHMAKER GAL4 Two-Hybrid System 3) and regular molecular biologic techniques were undertaken to screen human brain cDNA library with mutant ataxin-3 bait. Two baits from both normal and mutant C-terminus of ataxin-3 were created by subcloned methods to determine which domain of ataxin-3 interacts with the putative associated proteins and to find out optimal candidate proteins that interact with C-terminus of ataxin-3. Confocal microscope was used to observe whether ataxin-3 co-localized with the obtained interacting proteins in mammalian cells.RESULTS:Five novel ataxin-3 interacting proteins were obtained, among which were three known proteins, namely human rhodopsin guanosine diphosphate dissociation inhibitor alpha, small ubiquitin-like modifier 1, and human neuronal amiloride-sensitive cation channel 2; the other two were unknown. Interacting domain analysis revealed that an unknown protein interacted with the C-terminus near the polyglutamine tract of ataxin-3, the other four all interacted with the N-terminus. In the nucleus of SH-SY5Y cell, small ubiquitin-like modifier 1 co-localized with the wild-type ataxin-3 and with the intranuclear aggregates formed by the mutant ataxin-3.CONCLUSION:An unknown protein probably interacting with C-terminus of ataxin-3 is firstly discovered, and the initiative findings suggest first that the interaction of small ubiquitin-like modifier 1 with N-terminus of ataxin-3 and the relevant sumoylation probably participate in the post-translation modifying of ataxin-3 and in the pathogenesis of SCA3/MJD.

PML-II recruits ataxin-3 to PML-NBs and inhibits its deubiquitinating activity

Research on Screening and Identification of Proteins Interacting with Ataxin-3.

The Highly Conserved Region Within Exonuclease III-like in PML-I Regulates the Cytoplasmic Localization of PML-NBs

Microtubule-associated Protein 1 Light Chain 3 Interacts with and Contributes to Growth Inhibiting Effect of PML.

PML3 Orchestrates the Nuclear Dynamics and Function of TIP60

Stabilization of PML Nuclear Localization by Conjugation and Oligomerization of SUMO-3.

C-terminal motifs in PML isoforms critically regulate PML-NB formation.

Coiled-coil Domain of PML is Essential for the Aberrant Dynamics of PML-RARα, Resulting in Sequestration and Decreased Mobility of SMRT

Contribution of the C-Terminal Regions of Promyelocytic Leukemia Protein (pml) Isoforms Ii and V to Pml Nuclear Body Formation

Characterization of Endogenous Human Promyelocytic Leukemia Isoforms

PML Nuclear Bodies and Apoptosis.

The BAG2 and BAG5 Proteins Inhibit the Ubiquitination of Pathogenic Ataxin3-80Q.

AXIN is an Essential Co-Activator for the Promyelocytic Leukemia Protein in P53 Activation

Involvement of PML-I in Reformation of PML Nuclear Bodies in Acute Promyelocytic Leukemia Cells by Leptomycin B

Palmitoyltransferase ZDHHC3 is essential for the oncogenic activity of PML/RARα in acute promyelocytic leukemia

Expression of expanded GGC repeats within NOTCH2NLC causes behavioral deficits and neurodegeneration in a mouse model of neuronal intranuclear inclusion disease

PML-II regulates ERK and AKT signal activation and IFNα-induced cell death

PML3 Interacts with TRF1 and is Essential for ALT-associated PML Bodies Assembly in U2OS Cells.

PML protein isoforms and the RBCC/TRIM motif

PolyQ-expanded Ataxin-3 Interacts with Full-Length Ataxin-3 in a Polyq Length-Dependent Manner

Aggregation of Polyglutamine-Expanded Ataxin-3 Sequesters Its Specific Interacting Partners into Inclusions: Implication in a Loss-of-function Pathology